Thomas E. Clancy, MD, has been named the inaugural Distinguished Scholar in Surgical Oncology at Brigham and Women’s Hospital thanks to a gift from Carmella R. Kletjian.
Thomas E. Clancy, MD
Associate Surgeon, Division of Surgical Oncology, Brigham and Women’s Hospital
Co-Director, Pancreatic and Biliary Tumor Center, Dana-Farber/Brigham and Women’s Cancer Center
Director, Program in Robotic/Minimally Invasive Pancreatic and Liver Surgery
Medical Director, Multispecialty Surgical Oncology, DF/BWCC in clinical affiliation with South Shore Hospital
Assistant Professor, Harvard Medical School
Dr. Clancy is a senior surgeon and Distinguished Scholar in Surgical Oncology in the Department of Surgery at Brigham and Women’s Hospital, where he is also the director of the Program in Robotic/Minimally Invasive Pancreatic and Liver Surgery. He is a senior staff member and surgical lead at the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and co-director of the Pancreas and Biliary Tumor Center at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Clancy received his medical degree from Harvard Medical School and completed general surgical residency at Brigham and Women’s Hospital, followed by a surgical oncology fellowship at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.
Dr. Clancy specializes in surgery for complex gastrointestinal malignancies, with a focus on pancreatic tumors, primary and metastatic liver tumors, biliary malignancies and neuroendocrine tumors. He has a particular focus on minimally invasive and robotic surgical techniques for gastrointestinal tumors.
An author of over 75 scientific publications, reviews and book chapters, Dr. Clancy works in a collaborative model with numerous basic and translational scientific researchers on projects related to the diagnosis and management of gastrointestinal malignancies and pancreatic disease, as well as clinical outcomes in pancreatic surgery.
